Terms: = Germ cell tumor AND CXCR4, D2S201E, 7852, ENSG00000121966, P61073, NPYY3R, NPY3R, HM89, NPYRL, LESTR, HSY3RR, LCR1, fusin, WHIM, NPYR, FB22, CD184
459 results:
1. Expression and clinical value of cxcr4 in high grade gastroenteropancreatic neuroendocrine neoplasms.
Pang C; Li Y; Shi M; Fan Z; Gao X; Meng Y; Liu S; Gao C; Su P; Wang X; Zhan H
Front Endocrinol (Lausanne); 2024; 15():1281622. PubMed ID: 38524630
[TBL] [Abstract] [Full Text] [Related]
2. Exploring the Interplay of RUNX2 and cxcr4 in Melanoma Progression.
Dalle Carbonare L; Minoia A; Vareschi A; Piritore FC; Zouari S; Gandini A; Meneghel M; Elia R; Lorenzi P; Antoniazzi F; Pessoa J; Zipeto D; Romanelli MG; Guardavaccaro D; Valenti MT
Cells; 2024 Feb; 13(5):. PubMed ID: 38474372
[TBL] [Abstract] [Full Text] [Related]
3. The potential crosstalk genes and molecular mechanisms between glioblastoma and periodontitis.
Huang JH; Chen Y; Kang YB; Yao ZJ; Song JH
Sci Rep; 2024 Mar; 14(1):5970. PubMed ID: 38472293
[TBL] [Abstract] [Full Text] [Related]
4. Whole-exome sequencing has revealed novel genetic characteristics in intracranial germ cell tumours in the Chinese.
Huang X; Huang J; Zhou X; Zhang C; Ding X; Wong PJC; Wang Y; Zhang R
Histopathology; 2024 Jun; 84(7):1199-1211. PubMed ID: 38409885
[TBL] [Abstract] [Full Text] [Related]
5. 68 Ga-Pentixafor PET/CT for In Vivo Imaging of cxcr4 Receptors in Glioma Demonstrating a Potential for Response Assessment to Radiochemotherapy: Preliminary Results.
Waheed A; Singh B; Watts A; Kaur H; Singh H; Dhingra K; Ahuja C; Madan R; Singh A; Radotra BD
Clin Nucl Med; 2024 Apr; 49(4):e141-e148. PubMed ID: 38350065
[TBL] [Abstract] [Full Text] [Related]
6. Unraveling the impact of cancer-associated fibroblasts on hypovascular pancreatic neuroendocrine tumors.
Lai TY; Chiang TC; Lee CY; Kuo TC; Wu CH; Chen YI; Hu CM; Maskey M; Tang SC; Jeng YM; Tien YW; Lee EYP; Lee WH
Br J Cancer; 2024 Apr; 130(7):1096-1108. PubMed ID: 38341509
[TBL] [Abstract] [Full Text] [Related]
7. Volumetric Parameters Derived from cxcr4-Directed PET/CT Predict Outcome in Patients with Gastrointestinal Neuroendocrine Carcinomas.
Michalski K; Schlötelburg W; Hartrampf P; Heinrich M; Serfling S; Buck AK; Werner RA; Kosmala A; Weich A
Mol Imaging Biol; 2024 Apr; 26(2):344-350. PubMed ID: 38332341
[TBL] [Abstract] [Full Text] [Related]
8. Tozasertib activates anti-tumor immunity through decreasing regulatory T cells in melanoma.
Wang Q; Liu W; Zhou H; Lai W; Hu C; Dai Y; Li G; Zhang R; Zhao Y
Neoplasia; 2024 Feb; 48():100966. PubMed ID: 38237304
[TBL] [Abstract] [Full Text] [Related]
9. Has-miR-300-GADD45B promotes melanoma growth via cell cycle.
Chen L; Fang C; Yuan X; Liu M; Wu P; Zhong L; Chen Z
Aging (Albany NY); 2023 Dec; 15(23):13920-13943. PubMed ID: 38070141
[TBL] [Abstract] [Full Text] [Related]
10. Bone Marrow Stromal cells inhibited the growth and metastasis of human U87 cells through delivering exosomal miR-506.
Zhang L; Ding Y; Zhou W; Xu X; Zheng J
Medicine (Baltimore); 2023 Dec; 102(49):e36582. PubMed ID: 38065867
[TBL] [Abstract] [Full Text] [Related]
11. Differential requirements for CD4+ T cells in the efficacy of the anti-PD-1+LAG-3 and anti-PD-1+CTLA-4 combinations in melanoma flank and brain metastasis models.
Phadke MS; Li J; Chen Z; Rodriguez PC; Mandula JK; Karapetyan L; Forsyth PA; Chen YA; Smalley KSM
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38056899
[TBL] [Abstract] [Full Text] [Related]
12. Chemokine Receptor cxcr4 Radioligand Targeted Therapy Using 177Lutetium-pentixather for Pulmonary Neuroendocrine Cancers.
Fath MA; Liu D; Ewald JT; Robles-Planells C; Tomanek-Chalkley AM; Graves SA; Howe JR; O'Dorisio TM; Rastogi P; Bellizzi AM; O'Dorisio MS; Menda Y; Spitz DR
Radiat Res; 2024 Jan; 201(1):35-47. PubMed ID: 37989124
[TBL] [Abstract] [Full Text] [Related]
13. Chemokine receptor cxcr4 interacts with nuclear receptor Nur77 and promote glioma invasion and progression.
Dai Y; Yu C; Zhou L; Cheng L; Ni H; Liang W
Brain Res; 2024 Jan; 1822():148647. PubMed ID: 37890573
[TBL] [Abstract] [Full Text] [Related]
14. Implantable SDF-1α-loaded silk fibroin hyaluronic acid aerogel sponges as an instructive component of the glioblastoma ecosystem: Between chemoattraction and tumor shaping into resection cavities.
Molina-Peña R; Ferreira NH; Roy C; Roncali L; Najberg M; Avril S; Zarur M; Bourgeois W; Ferreirós A; Lucchi C; Cavallieri F; Hindré F; Tosi G; Biagini G; Valzania F; Berger F; Abal M; Rousseau A; Boury F; Alvarez-Lorenzo C; Garcion E
Acta Biomater; 2024 Jan; 173():261-282. PubMed ID: 37866725
[TBL] [Abstract] [Full Text] [Related]
15. Tamoxifen as a modulator of CXCL12-cxcr4-CXCR7 chemokine axis: A breast cancer and glioblastoma view.
Gonçalves TL; de Araújo LP; Pereira Ferrer V
Cytokine; 2023 Oct; 170():156344. PubMed ID: 37639844
[TBL] [Abstract] [Full Text] [Related]
16. Mavorixafor, an Orally Bioavailable cxcr4 Antagonist, Increases Immune cell Infiltration and Inflammatory Status of tumor Microenvironment in Patients with Melanoma.
Andtbacka RHI; Wang Y; Pierce RH; Campbell JS; Yushak M; Milhem M; Ross M; Niland K; Arbeit RD; Parasuraman S; Bickley K; Yeung CC; Aicher LD; Smythe KS; Gan L
Cancer Res Commun; 2022 Aug; 2(8):904-913. PubMed ID: 36923305
[TBL] [Abstract] [Full Text] [Related]
17. A self-assembling cxcr4-targeted pyroptosis nanotoxin for melanoma therapy.
Zhao Z; Huang Y; Wang J; Lin H; Cao F; Li S; Li Y; Li Z; Liu X
Biomater Sci; 2023 Mar; 11(6):2200-2210. PubMed ID: 36745434
[TBL] [Abstract] [Full Text] [Related]
18. Cancer-Associated Fibroblasts Induce Proliferation and Therapeutic Resistance to Everolimus in Neuroendocrine tumors through STAT3 Activation.
Amin T; Viol F; Krause J; Fahl M; Eggers C; Awwad F; Schmidt B; Benten D; Ungefroren H; Fraune C; Clauditz TS; Sauter G; Izbicki JR; Lohse AW; Huber S; Schrader J
Neuroendocrinology; 2023; 113(5):501-518. PubMed ID: 36473454
[TBL] [Abstract] [Full Text] [Related]
19. Biomimetic Nanovaccines Potentiating Dendritic cell Internalization via cxcr4-Mediated Macropinocytosis.
Yang C; Zhang F; Chen F; Chang Z; Zhao Y; Shao D; Sun W; Dong WF; Wang Z
Adv Healthc Mater; 2023 Feb; 12(5):e2202064. PubMed ID: 36416257
[TBL] [Abstract] [Full Text] [Related]
20. Vascular endothelial growth factor-C in activating vascular endothelial growth factor receptor-3 and chemokine receptor-4 in melanoma adhesion.
Hlophe YN; Joubert AM
J Cell Mol Med; 2022 Dec; 26(23):5743-5754. PubMed ID: 36398426
[TBL] [Abstract] [Full Text] [Related]
[Next]
